LoginSignup
MoepJunior
@MoepJunior
3Settimana·

Why do positive corporate earnings lead to stock price declines?

4
19 Commenti
immagine del profilo
jkb92@jkb92
3Settimana
Why is a banana curved?
•
9
•
immagine del profilo
Endurance Life@MozartsGeist
3Settimana
@jkb92 Because she wants to grow toward the sun?
•
3
•
immagine del profilo
Dividendenopi👴@Dividendenopi
3Settimana
@jkb92 If it were straight, it wouldn't fit in the bowl
•
5
•
immagine del profilo
Klein-Anleger@Klein-Anleger
3Settimana
@jkb92 because I wouldn't buy a straight banana, and because Apple has already designed the banana emoji to be round 🍌
•
4
•
immagine del profilo
Endurance Life@MozartsGeist
3Settimana
@Klein-Anleger Speaking of Apple, when will we head north again?
••
immagine del profilo
Klein-Anleger@Klein-Anleger
3Settimana
@MozartsGeist They're almost at their all-time high—I don't think they're a bargain right now, but they're not overpriced either…
•
1
•
immagine del profilo
Endurance Life@MozartsGeist
3Settimana
Just under 10% down over the last 7 days
••
immagine del profilo
Ichbinak63@Ichbinak63
3Settimana
@jkb92 because she had been avoiding the GDR for years.
•
3
•
immagine del profilo
jkb92@jkb92
3Settimana
@MozartsGeist "to the sun" haha—that analogy would probably go over best with Novo shareholders
•
1
•
immagine del profilo
Seventrader@7Trader
3Settimana
@jkb92 because nobody went into the jungle and straightened them out 😆
•
4
•
immagine del profilo
Endurance Life@MozartsGeist
3Settimana
@jkb92 Tomorrow, the sun ☀️ might just show its best side.
•
1
•
immagine del profilo
EugeneKrabs@Danicx13
3Settimana
I don't get it anymore either. The stock just still can't seem to get going. Every brief rebound gets sold off, and then it goes back down. Positive news doesn't make a difference anymore.
At some point, a stock has to turn around.
I’m holding on because I’m already deep in the red anyway 😂—I’ll probably buy more at some point.
It’s bound to turn around eventually.
•
3
•
Markus@MarkusF
3Settimana
@Danicx13 It's a company based in the EU.
Actually, that's pretty normal these days.

And it also has a lot of "investors" who bought in when it was massively undervalued and are cashing out their 20–30% profits in less than 6 months.
•
1
•
immagine del profilo
Get_Rich_or_Die_Tryin@Get_Rich_or_Die_Tryin
3Settimana
•
3
•
immagine del profilo
Endurance Life@MozartsGeist
3Settimana
@Get_Rich_or_Die_Tryin Thank you for forwarding this.
••
immagine del profilo
BoldTake@BoldTake
3Settimana
The problem:
You’ve developed a drug for a HUGE market that isn’t selling in line with its market potential. Eli Lilli shows that the demand is there.

Patent cliff: There isn’t much potential for a new sales boom right now, and current patents are expiring.

The stock needs a new story…

This isn’t meant to be hate! I find the company itself exciting and the price is tempting… but you run the risk of the stock treading water for a long time here.
•
2
•
immagine del profilo
Dirk aus Stade@dirko68
3Settimana
It's a shame that Novo is mentioned specifically here, when the question is surely meant to be more general. Unfortunately, it’s becoming increasingly common for certain expectations to be heavily factored into the stock price beforehand, and then—even when those expectations aren’t quite met—the stock price takes a significant hit despite solid earnings figures.
•
1
•
immagine del profilo
Yoshika 🦋.@Yoshika
3Settimana
However, the only positive figure is the adjusted operating profit before the 6.3 billion in write-downs on the pipeline.
And even the revised forecast for 2026, on an adjusted basis, still shows revenue and operating profit in the range of 0 to -6% compared with 2025.
••
immagine del profilo
Yoshika 🦋.@Yoshika
3Settimana
@Yoshika
And depreciation specifically means that part of the pipeline is worth less than what’s on the books. And the next one has already been announced for Q3, following the ZEUS flop
••
Partecipa alla conversazione
IscrivitiAccesso